NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said after the close of the market on Tuesday that fourth-quarter revenues improved 4 percent year over year as the firm beat the average analyst estimate on the top and bottom lines.

The company took in $573.8 million in revenues for the three months ended Dec. 31, 2012, up from $550.2 million a year ago, easily surpassing the average analyst estimate of $558.7 million.

On a currency-neutral basis, revenues were up 6 percent year over year, Bio-Rad said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.